Metabolic syndrome and nonalcoholic fatty liver disease: Is insulin resistance the link? von Asrih, Mohamed, Jornayvaz, François R.

Volltext

Fibroblast Growth Factor 15/19: From Basic Functions to Therapeutic Perspectives von Somm, Emmanuel, Jornayvaz, François R

Volltext

Inflammation as a potential link between nonalcoholic fatty liver disease and insulin resistance von Asrih, Mohamed, Jornayvaz, François R

Volltext

Effects of Ketogenic Diets on Cardiovascular Risk Factors: Evidence from Animal and Human Studies von Kosinski, Christophe, Jornayvaz, François R

Volltext

Hypothyroidism-Associated Dyslipidemia: Potential Molecular Mechanisms Leading to NAFLD von Mavromati, Maria, Jornayvaz, Francois R.

Volltext

Low birth weight leads to obesity, diabetes and increased leptin levels in adults: the CoLaus study von Jornayvaz, François R, Vollenweider, Peter, Bochud, Murielle, Mooser, Vincent, Waeber, Gérard, Marques-Vidal, Pedro

Volltext

Diets and nonalcoholic fatty liver disease: The good and the bad von Asrih, Mohamed, Jornayvaz, François R

Volltext

Diacylglycerol Activation of Protein Kinase Cε and Hepatic Insulin Resistance von Jornayvaz, François R., Shulman, Gerald I.

Volltext

Interleukin-18 in metabolism: From mice physiology to human diseases von Somm, Emmanuel, Jornayvaz, François R

Volltext

Pathophysiology of NASH in endocrine diseases von Gariani, Karim, Jornayvaz, François R

Volltext

Non-alcoholic fatty liver disease in type 1 diabetes: Prevalence and pathophysiology von Memaj, Plator, Jornayvaz, François R

Volltext

Ketogenic Diet Impairs FGF21 Signaling and Promotes Differential Inflammatory Responses in the Liver and White Adipose Tissue von Asrih, Mohamed, Altirriba, Jordi, Rohner-Jeanrenaud, Françoise, Jornayvaz, François R

Volltext

Role of Oxidative Stress and Carcinoembryonic Antigen-Related Cell Adhesion Molecule 1 in Nonalcoholic Fatty Liver Disease von Memaj, Plator, Ouzerara, Zayd, Jornayvaz, François R

Volltext

GLP-1 receptor agonists effect on cognitive function in patients with and without type 2 diabetes von Monney, Marine, Jornayvaz, François R, Gariani, Karim

Volltext

Effects of Antidiabetic Drugs on Gut Microbiota Composition von Montandon, Sophie A, Jornayvaz, François R

Volltext

NADPH oxidases in healthy white adipose tissue and in obesity: function, regulation, and clinical implications von Jornayvaz, François R., Gariani, Karim, Somm, Emmanuel, Jaquet, Vincent, Bouzakri, Karim, Szanto, Ildiko

Volltext

Three Weeks Versus Six Weeks of Antibiotic Therapy for Diabetic Foot Osteomyelitis: A Prospective, Randomized, Noninferiority Pilot Trial von Gariani, Karim, Truong-Thanh Pham, Kressmann, Benjamin, Jornayvaz, Francois R., Gastaldi, Giacomo, Stafylakis, Dimitrios, Philippe, Jacques, Lipsky, Benjamin A., Uckay, Ilker

Volltext

Multi-technique comparison of atherogenic and MCD NASH models highlights changes in sphingolipid metabolism von Montandon, Sophie A., Somm, Emmanuel, Loizides-Mangold, Ursula, de Vito, Claudio, Dibner, Charna, Jornayvaz, François R.

Volltext

Endocrine causes of nonalcoholic fatty liver disease von Marino, Laura, Jornayvaz, François R

Volltext

Nonalcoholic fatty liver disease in type 1 diabetes: where are we? von Jornayvaz, François R

Volltext